Model-based meta-analysis: an important tool for making quantitative decisions during drug development (Q84839373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Model-based meta-analysis: an important tool for making quantitative decisions during drug development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

D R Mould

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

283-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

The Safety of Tiotropium — The FDA's Conclusions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

The promise and problems of meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.122

7 January 2021

Identifiers

DOI

10.1038/CLPT.2012.122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910485%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference